122 related articles for article (PubMed ID: 9870691)
1. Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with "multi-labelling subtraction immunostaining".
Yamada T; Sawatsubashi M; Yakushiji H; Itoh Y; Edakuni G; Mori M; Robert L; Miyazaki K
Virchows Arch; 1998 Dec; 433(6):567-70. PubMed ID: 9870691
[TBL] [Abstract][Full Text] [Related]
2. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.
Fava RA; Olsen NJ; Spencer-Green G; Yeo KT; Yeo TK; Berse B; Jackman RW; Senger DR; Dvorak HF; Brown LF
J Exp Med; 1994 Jul; 180(1):341-6. PubMed ID: 8006592
[TBL] [Abstract][Full Text] [Related]
3. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis.
Nagashima M; Yoshino S; Ishiwata T; Asano G
J Rheumatol; 1995 Sep; 22(9):1624-30. PubMed ID: 8523334
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
[TBL] [Abstract][Full Text] [Related]
5. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis.
Gotis-Graham I; Smith MD; Parker A; McNeil HP
Ann Rheum Dis; 1998 Nov; 57(11):664-71. PubMed ID: 9924208
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma.
Fukushima N; Satoh T; Sano M; Tokunaga O
Leuk Lymphoma; 2001 Aug; 42(4):709-20. PubMed ID: 11697501
[TBL] [Abstract][Full Text] [Related]
7. Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tryptase-positive, chymase-negative mast cells.
Buckley MG; Gallagher PJ; Walls AF
J Pathol; 1998 Sep; 186(1):67-74. PubMed ID: 9875142
[TBL] [Abstract][Full Text] [Related]
8. Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho-mediated signaling.
Sawamukai N; Yukawa S; Saito K; Nakayamada S; Kambayashi T; Tanaka Y
Arthritis Rheum; 2010 Apr; 62(4):952-9. PubMed ID: 20131259
[TBL] [Abstract][Full Text] [Related]
9. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.
Tetlow LC; Woolley DE
Ann Rheum Dis; 1995 Jul; 54(7):549-55. PubMed ID: 7668897
[TBL] [Abstract][Full Text] [Related]
10. Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro.
Tetlow LC; Harper N; Dunningham T; Morris MA; Bertfield H; Woolley DE
Ann Rheum Dis; 1998 Jan; 57(1):25-32. PubMed ID: 9536819
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor.
Tóth-Jakatics R; Jimi S; Takebayashi S; Kawamoto N
Hum Pathol; 2000 Aug; 31(8):955-60. PubMed ID: 10987256
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Fraser A; Fearon U; Reece R; Emery P; Veale DJ
Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
[TBL] [Abstract][Full Text] [Related]
13. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.
Imada A; Shijubo N; Kojima H; Abe S
Eur Respir J; 2000 Jun; 15(6):1087-93. PubMed ID: 10885428
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells.
Palmer HS; Kelso EB; Lockhart JC; Sommerhoff CP; Plevin R; Goh FG; Ferrell WR
Arthritis Rheum; 2007 Nov; 56(11):3532-40. PubMed ID: 17968878
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.
Hitchon C; Wong K; Ma G; Reed J; Lyttle D; El-Gabalawy H
Arthritis Rheum; 2002 Oct; 46(10):2587-97. PubMed ID: 12384916
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietins, growth factors, and vascular morphology in early arthritis.
Fearon U; Griosios K; Fraser A; Reece R; Emery P; Jones PF; Veale DJ
J Rheumatol; 2003 Feb; 30(2):260-8. PubMed ID: 12563678
[TBL] [Abstract][Full Text] [Related]
18. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
[TBL] [Abstract][Full Text] [Related]
20. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in 12 patients monitored for 10 years.
Latour F; Zabraniecki L; Dromer C; Brouchet A; Durroux R; Fournié B
Joint Bone Spine; 2001 Dec; 68(6):493-8. PubMed ID: 11808986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
